+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Assisted Reproductive Technology Market By Procedure, By Technology, Frozen Embryo Replacement, By Type, And By End Use Forecasts To 2027

  • ID: 5206656
  • Report
  • June 2020
  • Region: Global
  • 295 Pages
  • Reports and Data

FEATURED COMPANIES

  • Anecova (Switzerland)
  • Celmatix Inc. (US)
  • FertiPro N.V. (Belgium)
  • OvaScience (US)
  • Vitroife AB (Sweden)
The rising awareness about possible artificial conception methodologies and increasing incidences of advanced maternal age are driving the demand for the market.

Market Size in 2019 - USD 24.21 Billion, Market Growth - CAGR of 9.9% over the forecast period, Market Trends - Growing awareness about being able to conceive with the help of modern technology.

The Global Assisted Reproductive Technology (ART) Market is forecast to reach USD 50.71 Billion by 2027, according to our latest report. Assisted reproductive technology (ART) is an infertility treatment, wherein a laboratory fusion of ovule extracted from the women's ovaries are mixed with the male sperms. There has been a dramatic rise in the number of women who are choosing to conceive after the age of 35. This progression started in the mid-1970s in the U.S. and has proceeded to grow slowly over time. 15% of the birth-giving people today are aged 35 and above, up from 11% in 2002 and 8% in 1990. With the trend of delayed pregnancies across different parts of the world, the use of ovulation test kits is anticipated to grow significantly.

Globally, approximately 0.3% of all infants born every year are conceived using assisted reproductive technology (ART). Growing awareness of assisted reproductive technology and diminished discomfort around pregnancy-related disorders in the social scenario has contributed a sufficient boost to the assisted reproductive technology market. Statistics provided by the World Fertility Patterns show that Mexico's birth rate is around 2 kids per mother, well below the levels required to support the current population of Mexico. Brazil's birth rate is also lower, at 1.75, close to that of Colombia's 1.77, while Costa Rica is at 1.66. These declining fertility rates can be threatening for women and parents planning to conceive. Thus, more couples are opting for the artificial pregnancy method.

A major market limiting factor is the stringent rules and regulations. The transfer of multiple embryos in a single cycle increases the rates of multiple births. Due to the increased social costs and health risks associated with multiple births, legislations or guidelines from professional societies have been introduced in many countries. Moreover, a moderate success rate is expected to act as a restraining factor for the global market in the years ahead.

The COVID-19 Impact:

The recent outbreak of COVID-19 has impacted the growth of the market in several countries as elective procedures, like IVF and other ART procedures, are being postponed or canceled. Many studies have stated that women trying to conceive through ART are vulnerable to infection due to lower immunity. The restricted movements and shutdown of the ART facilities in developed as well as developing nations have resulted in a reduction of couples approaching ART. However, various gynecologists are maintaining the routine or follow-up of surrogate or couples enlisted under ART procedures through a digital platform. However, after this temporary decline in growth, the market is estimated to grow in the latter phase of 2021.

Further key findings from the report suggest
  • North America dominated the market with a revenue of USD 9.13 billion in 2019. In the region, the embryo/egg banking segment accounted for 2.17 billion market revenue in 2019 and is anticipated to grow USD 3.70 billion in 2027. This can be due to the changing lifestyle and increased adoption of late pregnancy.
  • The In-Vitro Fertilization (IVF) technology segment dominated the market. In 2019, the segment generated USD 21.68 billion in revenue. Access to government-subsidized schemes and the development of less cost-intensive IVF techniques is expected to drive the demand for ART in respective regions.
  • Other emerging types of ART, such as Gamete-Intra Fallopian Transfer (GIFT) and Zygote-Intra Fallopian Transfer (ZIFT), are anticipated to increase at a significant CAGR from 2020 to 2027.
  • The continuous rise in cases of infertility is expected to create future revenue opportunities for the ART market.
  • Key participants in the ART market are Merck KGaA (Germany), Cooper Surgical (Denmark), Fujifilm Irvine Scientific (U.S.), Vitroife AB (Sweden), Thermo Fisher Scientific (U.S.), Celmatix, Inc. (U.S.), Anecova (Switzerland), OvaScience (U.S.), Ferring Pharmaceuticals (U.S.), and FertiPro N.V. (Belgium).

For the purpose of this report, Reports and Data has segmented into the global Assisted Reproductive Technology Market on the basis of procedure, technology, type, end-use, and region:

Procedure Outlook (Revenue, USD Billion; 2017-2027)
  • Fresh Donor
  • Fresh Non-Donor
  • Frozen Donor
  • Frozen Non-Donor
  • Embryo/Egg Banking

Technology Outlook (Revenue, USD Billion; 2017-2027)
  • In-Vitro Fertilization (IVF)
  • IVF Using Intra-Cytoplasmic Sperm Injection (ICSI)
  • IVF Without Using Intra-Cytoplasmic Sperm Injection (ICSI)
  • Pre-Implantation Genetic Screening (PGS)
  • Frozen Embryo Replacement (FER)
  • Others

Type Outlook (Revenue, USD Billion; 2017-2027)
  • Artificial Insemination
  • Surrogacy
  • Ovulation Induction
  • Others

End-Use Outlook (Revenue, USD Billion; 2017-2027)
  • Fertility Clinics
  • Hospitals
  • Clinical Research
  • Others

Regional Outlook (Revenue, USD Billion; 2017-2027)
  • North America
  • U.S.
  • Europe
  • U.K.
  • France
  • Asia Pacific
  • China
  • India
  • Japan
  • Latin America
  • Brazil
  • Middle East & Africa

Reasons to Buy the Report
  • A robust analysis and estimation of the Assisted Reproductive Technology (ART) Market with four levels of quality check - in-house database, expert interviews, governmental regulation, and a forecast specifically done through time series analysis
  • A holistic competitive landscape of the all the major players in the Assisted Reproductive Technology (ART) market. The report covers their market shares, strategic initiatives, new product launches, R&D expenditure, M&As, Joint ventures, expansionary plans, product wise metric space analysis and key developments
  • Go-to-market strategies specifically formulated in line with location analysis which takes into the factors such as government regulations, supplier mapping, supply chain obstacles, and feedback from local vendors
  • Most deep dive segmental bifurcation available currently in the market. Our stellar methodology helps us understand the overall gamut of the supply chain and will help you explain the current market dynamics
  • Special focus given on vendor landscape, supplier portfolio, customer mapping, production capacity, and yearly capacity utilization
Note: Product cover images may vary from those shown

FEATURED COMPANIES

  • Anecova (Switzerland)
  • Celmatix Inc. (US)
  • FertiPro N.V. (Belgium)
  • OvaScience (US)
  • Vitroife AB (Sweden)

Chapter 1. Market Synopsis
1.1. Market Definition
1.2. Research Scope & Premise
1.3. Methodology
1.4. Market Estimation Technique
Chapter 2. Executive Summary
2.1. Summary Snapshot, 2017 - 2027
Chapter 3. Indicative Metrics
Chapter 4. COVID 19 impact assessment
4.1. Assisted reproductive technology Industry Outlook
4.1.1.1. Q1 2020
4.1.1.2. Q2 2020
4.1.1.3. Q3 2020
4.2. Increasing demand for Assisted reproductive technology due to COVID 19 pandemic Crisis
4.2.1. Scenario 1: Assisted reproductive technology market decreased by xx%
4.2.1.1. Scenario 1 timeline
4.2.1.2. Key indicators for scenario 1
4.2.1.3. Covid-19 virus impact on global Assisted reproductive technology market revenue, 2019-2027: scenario-1
4.2.2. Scenario-2: Assisted reproductive technology market slightly declines by xx%
4.2.2.1. Scenario 2 timeline
4.2.2.2. Key indicators for scenario 2
4.2.2.3. Covid-19 virus impact on global Assisted reproductive technology market revenue, 2019-2027: scenario-2
4.2.3. Scenario-3: Assisted reproductive technology market grows by xx%
4.2.3.1. Scenario 3 timeline
4.2.3.2. Key indicators for scenario 3
4.2.3.3. Covid-19 virus impact on global Assisted reproductive technology market revenue, 2019-2027: scenario-3
4.2.4. Scenario-4: Assisted reproductive technology market grows by xx%
4.2.4.1. Scenario 4 timeline
4.2.4.2. Key indicators for scenario 4
4.2.4.3. Covid-19 virus impact on global Assisted reproductive technology market revenue, 2019-2027: scenario-4
4.3. Supply chain stabilization
4.3.1.1. Supply scenario
4.3.1.2. Demand scenario
4.4. Upcoming strategies required to combat the current situation
Chapter 5. Assisted reproductive technology Segmentation & Impact Analysis
5.1. Assisted reproductive technology Segmentation Analysis
5.2. Assisted reproductive technology Market Value Chain Analysis, 2017-2027
5.3. Regulatory framework
5.4. Assisted reproductive technology Market Impact Analysis
5.4.1. Market driver analysis
5.4.1.1. A rise in ovulation disorders
5.4.1.2. Rising knowledge and acceptance of assisted reproductive technologies socially
5.4.1.3. The continuous growth in infertility rate
5.4.2. Market restraint analysis
5.4.2.1. Stringent rules and regulations
5.5. Key opportunities prioritized
5.6. Assisted reproductive technology Pricing Analysis
5.7. Industry analysis - Porter's
5.8. Assisted reproductive technology PESTEL Analysis
Chapter 6. Assisted reproductive technology Market By Procedures Insights & Trends
6.1. Assisted reproductive technology by procedure dynamics & Market Share, 2019 & 2027
6.2. Fresh Donor
6.2.1. Market estimates and forecast, 2017 - 2027 (USD Million)
6.2.2. Market estimates and forecast, by region, 2017 - 2027 (USD Million)
6.3. Fresh Non-Donor
6.3.1. Market estimates and forecast, 2017 - 2027 (USD Million)
6.3.2. Market estimates and forecast, by region, 2017 - 2027 (USD Million)
6.4. Frozen Donor
6.4.1. Market estimates and forecast, 2017 - 2027 (USD Million)
6.4.2. Market estimates and forecast, by region, 2017 - 2027 (USD Million)
6.5. Frozen Non Donor
6.5.1. Market estimates and forecast, 2017 - 2027 (USD Million)
6.5.2. Market estimates and forecast, by region, 2017 - 2027 (USD Million)
6.6. Embryo/Egg Banking
6.6.1. Market estimates and forecast, 2017 - 2027 (USD Million)
6.6.2. Market estimates and forecast, by region, 2017 - 2027 (USD Million)
Chapter 7. Assisted reproductive technology Market By Technology Insights & Trends
7.1. Assisted reproductive technology by technology dynamics & Market Share, 2019 & 2027
7.2. In-Vitro Fertilization (IVF)
7.2.1. Market estimates and forecast, 2017 - 2027 (USD Million)
7.2.2. Market estimates and forecast, by region, 2017 - 2027 (USD Million)
7.2.3. IVF Using Intra-Cytoplasmic Sperm Injection (ICSI)
7.2.3.1. Market estimates and forecast, 2017 - 2027 (USD Million)
7.2.3.2. Market estimates and forecast, by region, 2017 - 2027 (USD Million)
7.2.4. IVF Without Using Intra-Cytoplasmic Sperm Injection (ICSI)
7.2.4.1. Market estimates and forecast, 2017 - 2027 (USD Million)
7.2.4.2. Market estimates and forecast, by region, 2017 - 2027 (USD Million)
7.3. Pre-Implantation Genetic Screening (PGS)
7.3.1. Market estimates and forecast, 2017 - 2027 (USD Million)
7.3.2. Market estimates and forecast, by region, 2017 - 2027 (USD Million)
7.4. Frozen Embryo Replacement (FER)
7.4.1. Market estimates and forecast, 2017 - 2027 (USD Million)
7.4.2. Market estimates and forecast, by region, 2017 - 2027 (USD Million)
7.5. Others
7.5.1. Market estimates and forecast, 2017 - 2027 (USD Million)
7.5.2. Market estimates and forecast, by region, 2017 - 2027 (USD Million)
Chapter 8. Assisted reproductive technology Market By Type Insights & Trends
8.1. Assisted reproductive technology by type dynamics & Market Share, 2019 & 2027
8.2. Artificial Insemination
8.2.1. Market estimates and forecast, 2017 - 2027 (USD Million)
8.2.2. Market estimates and forecast, by region, 2017 - 2027 (USD Million)
8.3. Surrogacy
8.3.1. Market estimates and forecast, 2017 - 2027 (USD Million)
8.3.2. Market estimates and forecast, by region, 2017 - 2027 (USD Million)
8.4. Ovulation Induction
8.4.1. Market estimates and forecast, 2017 - 2027 (USD Million)
8.4.2. Market estimates and forecast, by region, 2017 - 2027 (USD Million)
8.5. Others
8.5.1. Market estimates and forecast, 2017 - 2027 (USD Million)
8.5.2. Market estimates and forecast, by region, 2017 - 2027 (USD Million)
Chapter 9. Assisted reproductive technology Market By End Use Insights & Trends
9.1. Assisted reproductive technology by end use dynamics & Market Share, 2019 & 2027
9.2. Fertility Clinics
9.2.1. Market estimates and forecast, 2017 - 2027 (USD Million)
9.2.2. Market estimates and forecast, by region, 2017 - 2027 (USD Million)
9.3. Hospitals
9.3.1. Market estimates and forecast, 2017 - 2027 (USD Million)
9.3.2. Market estimates and forecast, by region, 2017 - 2027 (USD Million)
9.4. Clinical Research
9.4.1. Market estimates and forecast, 2017 - 2027 (USD Million)
9.4.2. Market estimates and forecast, by region, 2017 - 2027 (USD Million)
9.5. Others
9.5.1. Market estimates and forecast, 2017 - 2027 (USD Million)
9.5.2. Market estimates and forecast, by region, 2017 - 2027 (USD Million)
Chapter 10. Assisted reproductive technology Market Regional Outlook
10.1. Assisted reproductive technology Market share by region, 2019 & 2027
10.2. North America
10.2.1. North America Assisted reproductive technology Market estimates and forecast, 2017 - 2027, (USD Million)
10.2.2. North America Assisted reproductive technology Market estimates and forecast by Procedures, 2017 - 2027, (USD Million)
10.2.3. North America Assisted reproductive technology Market estimates and forecast by Technology, 2017 - 2027, (USD Million)
10.2.4. North America Assisted reproductive technology Market estimates and forecast by Type, 2017 - 2027, (USD Million)
10.2.5. North America Assisted reproductive technology Market estimates and forecast by End Use, 2017 - 2027, (USD Million)
10.2.6. U.S.
10.2.6.1. U.S. Assisted reproductive technology Market estimates and forecast, 2017 - 2027, (USD Million)
10.2.6.2. U.S. Assisted reproductive technology Market estimates and forecast by Procedures, 2017 - 2027, (USD Million)
10.2.6.3. U.S. Assisted reproductive technology Market estimates and forecast by Technology, 2017 - 2027, (USD Million)
10.2.6.4. U.S. Assisted reproductive technology Market estimates and forecast by Type, 2017 - 2027, (USD Million)
10.2.6.5. U.S. Assisted reproductive technology Market estimates and forecast by End Use, 2017 - 2027, (USD Million)
10.2.7. Canada
10.2.7.1. Canada Assisted reproductive technology Market estimates and forecast, 2017 - 2027, (USD Million)
10.2.7.2. Canada Assisted reproductive technology Market estimates and forecast by Procedures, 2017 - 2027, (USD Million)
10.2.7.3. Canada Assisted reproductive technology Market estimates and forecast by Technology, 2017 - 2027, (USD Million)
10.2.7.4. Canada Assisted reproductive technology Market estimates and forecast by Type, 2017 - 2027, (USD Million)
10.2.7.5. Canada Assisted reproductive technology Market estimates and forecast by End Use, 2017 - 2027, (USD Million)
10.3. Europe
10.3.1. Europe Assisted reproductive technology Market estimates and forecast, 2017 - 2027, (USD Million)
10.3.2. Europe Assisted reproductive technology Market estimates and forecast by Procedures, 2017 - 2027, (USD Million)
10.3.3. Europe Assisted reproductive technology Market estimates and forecast by Technology, 2017 - 2027, (USD Million)
10.3.4. Europe Assisted reproductive technology Market estimates and forecast by Type, 2017 - 2027, (USD Million)
10.3.5. Europe Assisted reproductive technology Market estimates and forecast by End Use, 2017 - 2027, (USD Million)
10.3.6. Germany
10.3.6.1. Germany Assisted reproductive technology Market estimates and forecast, 2017 - 2027, (USD Million)
10.3.6.2. Germany Assisted reproductive technology Market estimates and forecast by Procedures, 2017 - 2027, (USD Million)
10.3.6.3. Germany Assisted reproductive technology Market estimates and forecast by Technology, 2017 - 2027, (USD Million)
10.3.6.4. Germany Assisted reproductive technology market estimates and forecast by Type, 2017 - 2027, (USD Million)
10.3.6.5. Germany Assisted reproductive technology market estimates and forecast by End Use, 2017 - 2027, (USD Million)
10.3.7. France
10.3.7.1. France Assisted reproductive technology Market estimates and forecast, 2017 - 2027, (USD Million)
10.3.7.2. France Assisted reproductive technology Market estimates and forecast by Procedures, 2017 - 2027, (USD Million)
10.3.7.3. France Assisted reproductive technology Market estimates and forecast by Technology, 2017 - 2027, (USD Million)
10.3.7.4. France Assisted reproductive technology market estimates and forecast by Type, 2017 - 2027, (USD Million)
10.3.7.5. France Assisted reproductive technology market estimates and forecast by End Use, 2017 - 2027, (USD Million)
10.3.8. U.K.
10.3.8.1. U.K Assisted reproductive technology market estimates and forecast, 2017 - 2027, (USD Million)
10.3.8.2. U.K Assisted reproductive technology market estimates and forecast by Procedures, 2017 - 2027, (USD Million)
10.3.8.3. U.K Assisted reproductive technology market estimates and forecast by Technology, 2017 - 2027, (USD Million)
10.3.8.4. U.K. Assisted reproductive technology market estimates and forecast by Type, 2017 - 2027, (USD Million)
10.3.8.5. U.K. Assisted reproductive technology market estimates and forecast by End Use, 2017 - 2027, (USD Million)
10.3.9. Rest of Europe
10.3.9.1. Rest of Europe Assisted reproductive technology market estimates and forecast, 2017 - 2027, (USD Million)
10.3.9.2. Rest of Europe Assisted reproductive technology market estimates and forecast by Procedures, 2017 - 2027, (USD Million)
10.3.9.3. Rest of Europe Assisted reproductive technology market estimates and forecast by Technology, 2017 - 2027, (USD Million)
10.3.9.4. Rest of Europe Assisted reproductive technology market estimates and forecast by Type, 2017 - 2027, (USD Million)
10.3.9.5. Rest of Europe Assisted reproductive technology market estimates and forecast by End Use, 2017 - 2027, (USD Million)
10.4. Asia Pacific
10.4.1. Asia Pacific Assisted reproductive technology market estimates and forecast, 2017 - 2027, (USD Million)
10.4.2. Asia Pacific Assisted reproductive technology market estimates and forecast by Procedures, 2017 - 2027, (USD Million)
10.4.3. Asia Pacific Assisted reproductive technology market estimates and forecast by Technology, 2017 - 2027, (USD Million)
10.4.4. Asia Pacific Assisted reproductive technology market estimates and forecast by Type, 2017 - 2027, (USD Million)
10.4.5. Asia Pacific Assisted reproductive technology market estimates and forecast by End Use, 2017 - 2027, (USD Million)
10.4.6. China
10.4.6.1. China Assisted reproductive technology market estimates and forecast, 2017 - 2027, (USD Million)
10.4.6.2. China Assisted reproductive technology market estimates and forecast by Procedures, 2017 - 2027, (USD Million)
10.4.6.3. China Assisted reproductive technology market estimates and forecast by Technology, 2017 - 2027, (USD Million)
10.4.6.4. China Assisted reproductive technology market estimates and forecast by Type, 2017 - 2027, (USD Million)
10.4.6.5. China Assisted reproductive technology market estimates and forecast by End Use, 2017 - 2027, (USD Million)
10.4.7. Japan
10.4.7.1. Japan Assisted reproductive technology market estimates and forecast, 2017 - 2027, (USD Million)
10.4.7.2. Japan Assisted reproductive technology market estimates and forecast by Procedures, 2017 - 2027, (USD Million)
10.4.7.3. Japan Assisted reproductive technology market estimates and forecast by Technology, 2017 - 2027, (USD Million)
10.4.7.4. Japan Assisted reproductive technology market estimates and forecast by Type, 2017 - 2027, (USD Million)
10.4.7.5. Japan Assisted reproductive technology market estimates and forecast by End Use, 2017 - 2027, (USD Million)
10.4.8. India
10.4.8.1. India Assisted reproductive technology market estimates and forecast, 2017 - 2027, (USD Million)
10.4.8.2. India Assisted reproductive technology market estimates and forecast by Procedures, 2017 - 2027, (USD Million)
10.4.8.3. India Assisted reproductive technology market estimates and forecast by Technology, 2017 - 2027, (USD Million)
10.4.8.4. India Assisted reproductive technology market estimates and forecast by Type, 2017 - 2027, (USD Million)
10.4.8.5. India Assisted reproductive technology market estimates and forecast by End use, 2017 - 2027, (USD Million)
10.4.9. Rest of Asia Pacific
10.4.9.1. Rest of Asia Pacific Assisted reproductive technology market estimates and forecast, 2017 - 2027, (USD Million)
10.4.9.2. Rest of Asia Pacific Assisted reproductive technology market estimates and forecast by Procedures, 2017 - 2027, (USD Million)
10.4.9.3. Rest of Asia Pacific Assisted reproductive technology market estimates and forecast by Technology, 2017 - 2027, (USD Million)
10.4.9.4. Rest of Asia Pacific Assisted reproductive technology market estimates and forecast by Type, 2017 - 2027, (USD Million)
10.4.9.5. Rest of Asia Pacific Assisted reproductive technology market estimates and forecast by End Use, 2017 - 2027, (USD Million)
10.5. Middle East & Africa
10.5.1. Middle East and Africa Assisted reproductive technology market estimates and forecast, 2017 - 2027, (USD Million)
10.5.2. Middle East and Africa Assisted reproductive technology market estimates and forecast by Procedures, 2017 - 2027, (USD Million)
10.5.3. Middle East and Africa Assisted reproductive technology market estimates and forecast by Technology, 2017 - 2027, (USD Million)
10.5.4. Middle East and Africa Assisted reproductive technology market estimates and forecast by Type, 2017 - 2027, (USD Million)
10.5.5. Middle East and Africa Assisted reproductive technology market estimates and forecast by End Use, 2017 - 2027, (USD Million)
10.6. Latin America
10.6.1. Latin America Assisted reproductive technology market estimates and forecast, 2017 - 2027, (USD Million)
10.6.2. Latin America Assisted reproductive technology market estimates and forecast by Procedures, 2017 - 2027, (USD Million)
10.6.3. Latin America Assisted reproductive technology market estimates and forecast by Technology, 2017 - 2027, (USD Million)
10.6.4. Latin America Assisted reproductive technology market estimates and forecast by Type, 2017 - 2027, (USD Million)
10.6.5. Latin America Assisted reproductive technology market estimates and forecast by End Use, 2017 - 2027, (USD Million)
10.6.6. Brazil
10.6.6.1. Brazil Assisted reproductive technology market estimates and forecast, 2017 - 2027, (USD Million)
10.6.6.2. Brazil Assisted reproductive technology market estimates and forecast by Procedures, 2017 - 2027, (USD Million)
10.6.6.3. Brazil Assisted reproductive technology market estimates and forecast by Technology, 2017 - 2027, (USD Million)
10.6.6.4. Brazil Assisted reproductive technology market estimates and forecast by Type, 2017 - 2027, (USD Million)
10.6.6.5. Brazil Assisted reproductive technology market estimates and forecast by End use, 2017 - 2027, (USD Million)
Chapter 11. Competitive Landscape
11.1. Market Revenue Share by Manufacturers
11.2. Mergers & Acquisitions
11.3. Strategy Benchmarking
11.3.1. Partnership & Agreement
11.3.2. New Product Development
11.3.3. Mergers & Acquisitions
11.3.4. Investment & Expansion
11.4. Vendor Landscape
Chapter 12. Company Profiles
12.1. Merck KGaA
12.1.1. Company Overview
12.1.2. Financial Performance
12.1.3. Product Length Benchmarking
12.1.4. Strategic Initiatives
12.2. Cooper Surgical
12.2.1. Company Overview
12.2.2. Financial Performance
12.2.3. Product Length Benchmarking
12.2.4. Strategic Initiatives
12.3. Fujifilm Irvine Scientific
12.3.1. Company Overview
12.3.2. Financial Performance
12.3.3. Product Length Benchmarking
12.3.4. Strategic Initiatives
12.4. Vitroife AB
12.4.1. Company Overview
12.4.2. Financial Performance
12.4.3. Product Length Benchmarking
12.4.4. Strategic Initiatives
12.5. Thermo Fisher Scientific
12.5.1. Company Overview
12.5.2. Financial Performance
12.5.3. Product Length Benchmarking
12.5.4. Strategic Initiatives
12.6. Celmatix, Inc.
12.6.1. Company Overview
12.6.2. Financial Performance
12.6.3. Product Length Benchmarking
12.6.4. Strategic Initiatives
12.7. Anecova
12.7.1. Company Overview
12.7.2. Financial Performance
12.7.3. Product Length Benchmarking
12.7.4. Strategic Initiatives
12.8. OvaScience
12.8.1. Company Overview
12.8.2. Financial Performance
12.8.3. Product Length Benchmarking
12.8.4. Strategic Initiatives
12.9. Ferring Pharmaceuticals
12.9.1. Company Overview
12.9.2. Financial Performance
12.9.3. Product Length Benchmarking
12.9.4. Strategic Initiatives
12.10. FertiPro N.V.
12.10.1. Company Overview
12.10.2. Financial Performance
12.10.3. Product Length Benchmarking
12.10.4. Strategic Initiatives
Note: Product cover images may vary from those shown
  • Merck KGaA (Germany) Co.per Surgical (Denmark)
  • Fujifilm Irvine Scientific (US)
  • Vitroife AB (Sweden)
  • Thermo Fisher Scientific (US)
  • Celmatix Inc. (US)
  • Anecova (Switzerland)
  • OvaScience (US)
  • Ferring Pharmaceuticals (US)
  • FertiPro N.V. (Belgium)
Note: Product cover images may vary from those shown